Endothelial progenitor/stem cells in engineered vessels for vascular transplantation

被引:8
|
作者
Muniswami, Durai Murugan [1 ,2 ]
Reddy, L. Vinod Kumar [1 ]
Amirtham, Soosai Manickam [3 ]
Babu, Sandhya [4 ]
Raj, Arunai Nambi [1 ]
Sen, Dwaipayan [1 ]
Manivasagam, Geetha [1 ]
机构
[1] VIT, Ctr Biomat Cellular & Mol Theranost CBCMT, Vellore, Tamil Nadu, India
[2] Karpagam Acad Higher Educ Deemed Univ, Dept Microbiol, Coimbatore 641021, Tamil Nadu, India
[3] Christian Med Coll & Hosp, Dept Physiol, Vellore 632002, Tamil Nadu, India
[4] Sandhya Hosp, Vellore 632009, Tamil Nadu, India
关键词
D O I
10.1007/s10856-020-06458-7
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Dysfunction of blood vessel leads to aneurysms, myocardial infarction and other thrombosis conditions. Current treatment strategies are transplantation of blood vessels from one part of the body to other dysfunction area, or allogenic, synthetic. Due to shortage of the donor, painful dissection, and lack of efficacy in synthetic, there is a need for alternative to native blood vessels for transplantation. Methods: Human umbilical-cord tissue obtained from the hospital with the informed consent. Umbilical-cord blood vessels were isolated for decellularization and to establish endothelial cell culture. Cultured cells were characterized by immunophenotype, gene expression and in vitro angiogenesis assay. Decellularized blood vessels were recellularized with the endothelial progenitors and Wharton jelly, CL MSCs (1:1), which was characterized by MTT, biomechanical testing, DNA content, SEM and histologically. Bioengineered vessels were transplanted into the animal models to evaluate their effect. Results: Cultured cells express CD31 and CD14 determining endothelial progenitor cells (EPCs). EPCs expresses various factors such as angiopoitin1, VWF, RANTES, VEGF, BDNF, FGF1, FGF2, HGF, IGF, GDNF, NGF, PLGF, NT3, but fail to express NT4, EGF, and CNTF. Pro and anti-inflammatory cytokine expressions were noticed. Functionally, these EPCs elicit in vitro tube formation. Negligible DNA content and intact ECM confirms the efficient decellularization of tissue. The increased MTT activity in recellularized tissue determines proliferating cells and biocompatibility of the scaffolds. Moreover, significant (P<0.05) increase in maximum force and tensile of recellularized biomaterial as compared to the decellularized scaffolds. Integration of graft with host tissue, suggesting biocompatible therapeutic biomaterial with cells. Conclusion: EPCs with stem cells in engineered blood vessels could be therapeutically applicable in vascular surgery.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Endothelial progenitor cells for vascular medicine
    Asahara, Takayuki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 : 14 - 14
  • [22] Endothelial progenitor cells for vascular medicine
    Asahara, Takayuki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (05): : 841 - 845
  • [23] Endothelial progenitor cells and vascular repair
    Zhang, Min
    Malik, Asrar B.
    Rehman, Jalees
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (03) : 224 - 228
  • [24] Endothelial progenitor cells for vascular regeneration
    Asahara, T
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (01) : 355 - 355
  • [25] The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels
    Zeng, Wen
    Yuan, Wei
    Li, Li
    Mi, Jianhong
    Xu, Shangcheng
    Wen, Can
    Zhou, Zhenhua
    Xiong, Jiaqiang
    Sun, Jiansen
    Ying, Dajun
    Yang, Mingcan
    Li, Xiaosong
    Zhu, Chuhong
    BIOMATERIALS, 2010, 31 (07) : 1636 - 1645
  • [26] Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans
    Serena Scala
    Luca Basso-Ricci
    Francesca Dionisio
    Danilo Pellin
    Stefania Giannelli
    Federica Andrea Salerio
    Lorena Leonardelli
    Maria Pia Cicalese
    Francesca Ferrua
    Alessandro Aiuti
    Luca Biasco
    Nature Medicine, 2018, 24 : 1683 - 1690
  • [27] Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans
    Scala, Serena
    Basso-Ricci, Luca
    Dionisio, Francesca
    Pellin, Danilo
    Giannelli, Stefania
    Salerio, Federica Andrea
    Leonardelli, Lorena
    Cicalese, Maria Pia
    Ferrua, Francesca
    Aiuti, Alessandro
    Biasco, Luca
    NATURE MEDICINE, 2018, 24 (11) : 1683 - +
  • [28] MESENCHYMAL STEM CELLS-DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR IMPROVES CHARACTERISTICS OF ENDOTHELIAL PROGENITOR CELLS
    Fauza, D.
    Lagonda, C. A.
    Tjahjadi, F. B.
    Kusnadi, Y.
    CYTOTHERAPY, 2018, 20 (05) : S36 - S37
  • [29] Circulating endothelial progenitor cells in patients undergoing allogeneic stem cell transplantation
    Spiropoulos, A
    Goussetis, E
    Theodosaki, M
    Stefanaki, K
    Peristeri, I
    Kitra, V
    Petrakou, E
    Graphakos, S
    BONE MARROW TRANSPLANTATION, 2006, 37 : S308 - S308
  • [30] Endothelial repair by stem and progenitor cells
    Wang, Xuyang
    Wang, Ruilin
    Jiang, Liujun
    Xu, Qingbo
    Guo, Xiaogang
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 163 : 133 - 146